BARLA THOMAS: Open Payments
NPI 1568600617 · HENAGAR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$722 in 38 payments from 15 companies in 2025. Trend: 2023 $408 · 2024 $596 · 2025 $722
Food & beverage: $722
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $166 |
| Novo Nordisk Inc | 6 | $121 |
| Corcept Therapeutics | 3 | $71 |
| ABBVIE INC. | 3 | $64 |
| Lilly USA, LLC | 2 | $41 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Dexcom, Inc. | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
Products named: TRELEGY ELLIPTA, Ozempic, Korlym, SHINGRIX, VRAYLAR, GEMTESA, CAPLYTA, JARDIANCE.
Industry payments across AL — which companies pay providers there.
